Systems and methods for embolic implant detachment

Information

  • Patent Grant
  • 11147562
  • Patent Number
    11,147,562
  • Date Filed
    Wednesday, December 12, 2018
    6 years ago
  • Date Issued
    Tuesday, October 19, 2021
    3 years ago
Abstract
An aneurysm treatment system that includes an embolic implant, a delivery system, and an introducer sheath that are collectively designed so that the combination of the introducer sheath and the delivery system can be used as a deployment apparatus for the embolic implant. The delivery system can have a pull wire, a delivery tube, and an interference feature attached to the pull wire and positioned near a proximal end of the delivery tube. Rather than being discarded, the introducer sheath can be moved proximally over the delivery tube until it engages the interference feature. To deploy the implant, the introducer sheath can be pressed against the interference feature, causing the interference feature to move proximally in relation to the delivery tube, thereby proximally pulling the pull wire to which the interference feature is attached and deploying the implant.
Description
FIELD OF INVENTION

The present invention generally relates to aneurysm treatment devices and more particularly, to delivery systems for embolic implants.


BACKGROUND

Numerous intravascular implant devices are known in the field. Many are deployed mechanically, via systems that combine one or more catheters and wires for delivery. Examples of implants that can be delivered mechanically include embolic elements, stents, grafts, drug delivery implants, flow diverters, filters, stimulation leads, sensing leads, or other implantable structures delivered through a microcatheter. Some obstetric and gastrointestinal implants may also be implanted via similar systems that combine one or more catheters and wires. Devices that may be released or deployed by mechanical means vary greatly in design but can employ a similar delivery catheter and wire system. Many such catheter-based delivery systems include a wire for retention of the implant in the catheter until the time for release of the device. These systems are then actuated by retracting or pulling the wire relative to the catheter. Such a wire is referred to herein as a “pull wire”.


To pull the pull wire proximally to deploy the implant, a physician can use one of many known deployment apparatuses. Such mechanical deployment apparatuses are typically separate from the delivery system and have moving parts for gripping the pull wire and for moving the pull wire proximally. Deployment methods and apparatuses that do not require auxiliary components and/or complex moving parts can simplify treatment procedures and reduce cost. There is therefore a need for simplified mechanical implant deployment apparatuses.


SUMMARY

Disclosed herein are various exemplary systems, devices, and methods of the present invention that can address the above needs. Examples can generally include an embolic implantation system that includes an embolic implant, a delivery system, and an introducer sheath that are collectively designed so that the combination of the introducer sheath and the delivery system can be used as a deployment apparatus for the embolic implant. The delivery system can have a pull wire, a delivery tube, and an interference feature attached to the pull wire and positioned at a proximal end of the delivery tube. The introducer sheath can be moved proximally over the delivery tube until it engages the interference feature. To deploy the implant, the introducer sheath can be pressed against the interference feature, causing the interference feature to move proximally in relation to the delivery tube, thereby proximally pulling the pull wire to which the interference feature is attached and deploying the implant.


An example implantation system can include a delivery tube, an embolic coil, an introducer sheath, an interference feature, and an elongated member. The embolic coil can be detachably attached to a distal end of the delivery tube. The interference feature can be positioned at a proximal end of the delivery tube and movable in relation to the delivery tube. The elongated member can be positioned within a lumen of the delivery tube and attached to the interference feature. The introducer sheath can have a lumen sized to slidably receive the delivery tube and the embolic coil, the introducer sheath can be translatable over the delivery tube from the distal end of the delivery tube to the proximal end of the delivery tube, and the introducer sheath can be sized to engage the interference feature. The interference feature can be movable in relation to the delivery tube in response to a force applied by the introducer sheath against the interference feature. The elongated member can be movable in relation to the delivery tube in response to a proximal movement of the interference feature.


The interference feature can be detachable from the delivery tube. The elongated member can be movable to exit the proximal end of the delivery tube in response to a proximal movement of the detached interference feature.


The delivery tube can have a soft section near the distal end of the delivery tube. The length of the embolic coil and the soft section as measured from a distal end of the un-implanted embolic coil to a proximal end of the soft section can be shorter than the end-to-end length of the introducer sheath so that the introducer sheath is sized to fully encompass the un-implanted embolic coil and the soft section. The introducer sheath can be longer than the length of the embolic coil and soft section by about 5 cm.


The system can include a microcatheter, and the delivery tube can have an end-to-end length that is longer than the sum of the end-to-end length of the introducer sheath and an end-to-end length of the microcatheter.


The end-to-end length of the introducer sheath can be between about 46 cm to about 105 cm.


The introducer sheath can be movable from a packaged configuration in which the introducer sheath is positioned to completely encompass the soft section and the embolic coil to a deployment configuration in which the introducer sheath is engaged with the interference feature.


The embolic coil can be detached from the delivery tube by moving the elongated member proximally in relation to the delivery tube.


The interference feature can have a substantially circular surface positioned to engage the proximal end of the introducer sheath.


A distal end of the introducer sheath can be sized to engage a microcatheter to create an enclosed interface through which the embolic coil and at least a portion of the delivery tube can pass.


An example implantation assembly can include a delivery tube, an embolic implant, a pull wire, an engagement bump, and a tubular sheath. The embolic implant can be attached to a distal end of the delivery tube. The pull wire can be disposed within a lumen of the delivery tube and movable to detach the embolic implant from the delivery tube. The engagement bump can be disposed on a proximal end of the pull wire and positioned near a proximal end of the delivery tube. The tubular sheath can be conveyable over the embolic implant and the delivery tube from a distal end of the embolic implant to the proximal end of the delivery tube, and the tubular sheath can be sized to engage the engagement bump. The engagement bump and the pull wire can be movable in relation to the delivery tube in response to a force applied by the tubular sheath to the engagement bump.


The delivery tube can have a soft section extending proximally from the distal end of the delivery tube, and the tubular sheath can measure end-to-end about 5 cm longer than a length measured from a distal end of the embolic implant to a proximal end of the soft section when the embolic implant is attached to the delivery tube and extended in an un-implanted configuration.


The assembly can include a microcatheter, and the delivery tube can have an end-to-end length that is greater than the sum of the length of the introducer sheath and the microcatheter.


The tubular sheath can be movable from a packaged configuration in which the tubular sheath is positioned to completely encompass the soft section and the embolic coil to a deployment configuration in which the tubular sheath is engaged with the engagement bump.


The engagement bump can be detachable from the delivery tube in response to the force applied by the tubular sheath to the engagement bump. The pull wire can be movable to detach the embolic implant from the delivery tube in response to the force applied by the tubular sheath to the engagement bump.


An example method for treating an aneurysm can include the steps of providing an implantation system including an embolic implant, an introducer sheath, a delivery tube, an interference feature, and a pull wire; affixing the pull wire to the interference feature; positioning the pull wire within a lumen of the delivery tube; attaching the interference feature to a proximal end of the delivery tube; attaching the embolic implant at a distal end of the delivery tube; positioning the introducer sheath to encompass the embolic implant and a first portion of the delivery tube; sliding the introducer sheath proximally over the delivery tube; pulling the introducer sheath proximally to apply a force from the introducer sheath to the interference feature; and moving the interference feature and the pull wire proximally in relation to the delivery tube in response to the force.


The first portion of the delivery tube over which the introducer sheath is positioned in the example method can have a soft section. The method can include sizing the introducer sheath to have a length that is greater than the length of the embolic implant and the soft section by about 5 cm. The method can include sizing the introducer sheath to have a length of between about 46 cm to about 105 cm, the length measurable from a distal end to a proximal end of the introducer sheath.


The method can include detaching the embolic implant from the delivery tube in response to moving the interference feature and the pull wire proximally in relation to the delivery tube. The method can include detaching the interference feature from the delivery tube. The interference feature can be detached in response to moving the interference feature and the pull wire proximally in relation to the delivery tube.


The method can include providing a microcatheter; positioning the introducer sheath to engage with the microcatheter while maintaining the embolic implant and the first portion of the delivery tube within the inducer sheath; and translating the embolic implant and the delivery tube distally to position the embolic implant and the first portion of the delivery tube within the microcatheter.





BRIEF DESCRIPTION OF THE DRAWINGS

The above and further aspects of this invention are further discussed with reference to the following description in conjunction with the accompanying drawings, in which like numerals indicate like structural elements and features in various figures. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating principles of the invention. The figures depict one or more implementations of the inventive devices, by way of example only, not by way of limitation.



FIG. 1 is an illustration of an exemplary implantation system according to aspects of the present invention;



FIGS. 2A and 2B are illustrations of an exemplary implantation system such as illustrated in FIG. 1 interfacing with a microcatheter according to aspects of the present invention;



FIGS. 3A through 3C are illustrations of implantation steps that can be performed with an exemplary implantation system such as illustrated in FIG. 1 according to aspects of the present invention;



FIG. 4A illustrates an exemplary implantation system having a breakable disconnection feature according to aspects of the present invention;



FIG. 4B illustrates a cross-sectional view near a proximal end of the exemplary implantation system of FIG. 4A as indicated in FIG. 4A and according to aspects of the present invention;



FIG. 5A illustrates an exemplary implantation system having a twist-lock disconnection feature according to aspects of the present invention;



FIG. 5B illustrates a cross-sectional view near a proximal end of the exemplary implantation system of FIG. 5A as indicated in FIG. 5A and according to aspects of the present invention;



FIG. 6A illustrates an exemplary implantation system having a sliding track according to aspects of the present invention;



FIG. 6B illustrates a cross-sectional view near a proximal end of the exemplary implantation system of FIG. 6A as indicated in FIG. 6A and according to aspects of the present invention;



FIG. 7A illustrates an exemplary implantation system having a stretchable segment according to aspects of the present invention;



FIG. 7B illustrates a cross-sectional view near a proximal end of the exemplary implantation system of FIG. 7A as indicated in FIG. 7A and according to aspects of the present invention;



FIGS. 8A through 8C illustrate cut-away views of an exemplary implantation system having a stretchable segment and a disconnecting feature according to aspects of the present invention; and



FIG. 9 illustrates relative dimensions of a delivery system, microcatheter, and introducer sheath as known in the art.





DETAILED DESCRIPTION

Examples presented herein utilize an introducer sheath to facilitate mechanical deployment of an implant. Examples of implants that can be delivered mechanically include embolic elements, stents, grafts, drug delivery implants, flow diverters, filters, stimulation leads, sensing leads, or other implantable structures deliverable through a microcatheter. Some implants are currently packaged with an introducer sheath that is removed from the device and discarded near the beginning of an implantation procedure. For example, in existing systems, embolic coils and other embolic implants can be used to occlude vessels in a variety of medical applications. In many instances, prior to implantation and during handling of an embolic implant outside of a patient, the embolic implant is contained in an introducer sheath. In present treatment practices, once the embolic implant is transferred to a microcatheter, the introducer sheath would be removed from the delivery system and discarded before the embolic implant reaches a treatment site. In examples presented herein, according to the present invention, rather than being discarded, the introducer sheath can be slid proximally and can facilitate deployment of the embolic implant, i.e. detachment of the embolic implant from the delivery system. In order to use the introducer sheath to facilitate deployment, the delivery system can have an interference feature positioned at a proximal end of a delivery tube and attached to a pull wire, and the combination of the introducer sheath, delivery tube, pull wire, and interference feature can be configured such that the introducer sheath can engage with the interference feature and move the interference feature proximally in relation to the delivery tube, thereby pulling the pull wire proximally and deploying the embolic implant. The delivery tube, microcatheter, and introducer sheath can each have a respective length sized such that the introducer sheath can be long enough to cover the embolic implant and sensitive portions of the delivery system, and the delivery tube can be long enough to extend through the entire length of the microcatheter and the entire length of the introducer sheath.



FIG. 1 is an illustration of an exemplary implantation system 100. The implantation system 100 can have an embolic implant 140 such as an embolic coil, embolic braid, or other such implant for filling an aneurysm sac, a delivery tube 110 for delivering the embolic implant 140 to a treatment site, a pull wire 130 disposed within the delivery tube that can be pulled proximally to deploy the embolic implant 140, an interference feature 120 positioned at a proximal end 112 of the delivery tube 110 attached to the pull wire 130 that can be pulled proximally to pull the pull wire 130 proximally, and an introducer sheath 180 that can be moved proximally to engage the interference feature 120 and pull the interference feature 120 proximally.


The introducer sheath 180 can have a lumen therethrough that is sized to slidably receive the delivery tube 110 and the embolic implant 140. The introducer sheath 180 can be sized such that it can be translated proximally from the position illustrated in FIG. 1 over a length of the delivery tube 110 to engage the interference feature 120 positioned at the proximal end 112 of the delivery tube 110.


The interference feature 120 can be movable in relation to the delivery tube 110. For example, the interference feature 120 can be detachably attached to the proximal end 112 of the delivery tube 110, and the system 100 can include a disconnection feature 122 that can be unhooked, torn, broken, twisted, or otherwise manipulated to disconnect the interference feature 120 from the delivery tube 110.


The delivery tube 110 can have a soft section 116 positioned near a distal end 114 of the delivery tube 110 that has a greater flexibility than the remainder (proximal portion) 118 of the delivery tube 110. The embolic implant 140 can be detachably attached to a distal end 114 of the delivery tube 114. The soft section 116 can be designed to allow greater control and stability of the distal end 114 of the delivery tube 110 during implantation and deployment of the embolic implant 140. The soft section 116 can have laser cut notches or groves, and/or the soft section 116 can be made of a more flexible material compared to the remainder 118 of the delivery tube 110.


The introducer sheath 180 can serve the purpose of protecting (packaging) the embolic implant 140 and the soft section 116 of the delivery tube 110 as the system 100 is being handled prior to, and at the beginning of a patient treatment procedure. For this purpose, it is therefore desirable for the introducer sheath 180 to be long enough to completely encompass the embolic implant 140 and the soft section 116 prior to the treatment procedure. The combined length of the embolic implant 140 and the soft section 116 can be measured from a distal end 144 of the embolic implant 140 to a proximal end 117 of the soft section 116. The introducer sheath 180 can have a length measurable from a distal end 184 to a proximal end 182 of the introducer sheath that can be sized a few centimeters longer than the combined length of the embolic implant 140 and the soft section 116 to ensure that the embolic implant 140 and soft section 116 remain protected in case portions of the system 100 shift during handling prior to the treatment procedure. The introducer sheath 180 can have a length that is about 5 cm longer than the combined length of the embolic implant 140 and the soft section 116. For example, the embolic implant 140 can have a length of between about 1 cm and about 60 cm, the soft section 116 can have a length of about 40 cm, and the introducer sheath can have a length that is about 5 cm longer than the sum of the embolic implant 140 length and the soft section 116 length, i.e. between about 46 cm and about 105 cm.



FIGS. 2A and 2B are illustrations of an exemplary implantation system such as illustrated in FIG. 1 interfacing with a microcatheter 200. FIG. 2A illustrates an instant of a treatment procedure near the beginning of the treatment procedure in which an introducer sheath 180 is positioned to cover an embolic implant 140 and a soft portion 116 of a delivery tube 110 in a packaged configuration and a distal end 184 of the introducer sheath 180 is mated or engaged with a proximal end of the microcatheter 200. As shown in FIG. 2A, the distal end 184 of the introducer sheath 180 can be sized to engage the microcatheter 200 to create an enclosed interface through which the embolic implant 140 and the soft portion 116 of the delivery tube 110 can pass. The embolic implant 140 and the delivery tube 110 can be translated distally to push the embolic implant 140 and a portion of the delivery tube 110 into the microcatheter 200.



FIG. 2B illustrates an instant of the treatment procedure in which the embolic implant 140 and the soft portion 116 are positioned within the microcatheter 200. At the instant illustrated in FIG. 2B, the embolic implant 140 and the soft portion 116 are protected by the microcatheter 200 and the introducer sheath can now be pulled proximally 180 or left in place as the delivery tube 110 and embolic implant 140 are further translated distally.



FIGS. 3A through 3C are illustrations of an exemplary implantation system during a series of example implantation steps. FIG. 3A illustrates an embolic implant 140 and a soft portion 116 of a delivery tube 110 positioned inside a microcatheter 200 and an introducer sheath 180 being translated proximally over a proximal portion 118 of the delivery tube 110. As illustrated in FIG. 3A, the introducer sheath 180 can be disengaged from the microcatheter 200 and pulled proximally once the embolic implant 140 and soft section 116 are protected within the microcatheter 200, but before the embolic implant 140 is positioned at a treatment site or within an aneurysm. Alternatively, the introducer sheath 180 can remain engaged to the microcatheter until the embolic implant 140 is positioned at the treatment site or ready to be deployed from the delivery tube 110 and then pulled proximally after the embolic implant 140 is positioned at the treatment site.



FIG. 3B illustrates the introducer sheath 180 in a deployment configuration in which the introducer sheath 180 is engaged with an interference feature 120 positioned near a proximal end 112 of the delivery tube 110. The introducer sheath 180 is shown providing a force F against the interference feature 120. The force can be sufficient to move the interference feature 120 proximally in relation to the delivery tube 110. Prior to the application of the force F, the interference feature 120 can be detachably attached to the proximal end 112 of the delivery tube 110, and the interference feature 120 can be detached from the proximal end 112 of the delivery tube 110 in response to the force F. Alternatively, the interference feature 120 can remain attached to the delivery tube 110 and the force F can be sufficient to move the interference feature 120 in relation to the delivery tube 110.


The introducer sheath 180 can be sized to engage the interference feature 120. As illustrated, the introducer sheath 180 can be tubular and can have a circular proximal end 182, and the interference feature 120 can protrude radially beyond a circumference of the delivery tube 110. The interference feature 120 can be circular, having a circumference larger than a circumference of the proximal end 182 of the introducer sheath 180. The interference feature 120 can provide a flat surface against which the proximal end 182 of the introducer sheath 180 can press. Additionally, or alternatively, the interference feature can have a non-flat surface that can have a slope or a groove for receiving the introducer sheath 180. The interference feature 120 can be a bump positioned near the distal end of the delivery tube that extends beyond the circumference of the delivery tube and extends so that the introducer sheath 180, when slid proximally over the delivery tube 110, must engage the interference feature 120 before sliding completely over and off the proximal end 112 of the delivery tube 110.



FIG. 3C illustrates the interference feature 120 after being moved proximally in relation to the delivery tube 110 in response to the force F from the introducer sheath 180. The interference feature 120 can be attached to a pull wire 130, and the pull wire 130 can be pulled proximally when the interference feature 180 is moved proximally. The interference feature 120 can be detachably attached to the delivery tube 110 prior to the proximal movement of the interference feature 120, and a detachment feature 122 can be manipulated to facilitate the detachment of the interference feature 120. Once detached, the interference feature 120 can be pulled proximally away from the delivery tube 110, and the pull wire 130 can be moved to exit the proximal end 112 of the delivery tube 110 in response to the pulling of the interference feature 120. The pull wire 130 can be an elongated member that extends through a lumen of the delivery tube 110 toward the embolic implant 140. The pull wire 130 can constitute a component of a deployment system for releasing the embolic implant 140 at the distal end 114 of the delivery tube 110. When the pull wire 130 is pulled proximally, the pull wire 130 can initiate the deployment of the embolic implant 140. The embolic implant 140 can be detached from the delivery tube 110 in response to the proximal movement of the pull wire 130 in relation to the delivery tube 110.



FIG. 4A illustrates an exemplary implantation system having a breakable disconnection feature 122a. The implantation system can have an interference feature 120 detachably attached to a delivery tube 110 by the breakable disconnection feature 122a. The delivery tube 110 can include notches 115 that are areas in which material is removed from the delivery tube 110. The notches 115 can be positioned at a proximal end 112 of the delivery tube 110. The proximal end 112 of the delivery tube 110 can be attached to the interference feature 120 by gluing, welding, or other means. The notches 115 can be a breakable section 122a of the delivery tube 110. When an introducer sheath 180 is pressed against the interference feature 120, a force from the interference feature 120 can cause the breakable section 122a to break, and the interference feature 120 can then be moved proximally in relation to the delivery tube 110. The interference feature 120 can have a circular surface 124 against which the introducer sheath 180 can press. FIG. 4B is a cross-sectional view near a proximal end of the exemplary implantation system as indicated in FIG. 4A.



FIG. 5A illustrates an exemplary implantation system having a twist-lock disconnection feature 122b. The implantation system can have a delivery tube 110 with groove 113 cut at a proximal end 112 and an interference feature 120 that has a bump 123 or another feature that can engage the groove 113. The interference feature 120 can be detachably attached to the delivery tube 110 by the twist-lock disconnection feature (and/or a bayonet connector) 122b. The interference feature 120 can extend within a lumen of the delivery tube 110 at the proximal end 112 of the delivery tube 110 and have a bump or protrusion 123 that can be positioned in the groove 113 in the delivery tube 110 to maintain the attachment between the interference feature 120 and the delivery tube 110. The bump or protrusion 123 can be slid through the groove 113 to detach the interference feature 120 from the delivery tube 110. The groove 113 can be L shaped, and the interference feature 120 can be twisted in relation to the delivery tube 110 and then pulled proximally in relation to the delivery tube 110 to disconnect the twist-lock disconnection feature 122b. FIG. 5B illustrates a cross-sectional view near a proximal end of the exemplary implantation system as indicated in FIG. 5A.


While FIGS. 4A through 5B illustrate examples of an interference feature 120 that is movable in relation to the delivery tube 110 after detaching from the delivery tube 110, the interference feature need not be detached, and can be movable in relation to the delivery tube 110 without detaching. FIGS. 6A through 8C illustrate example systems wherein the interference feature 120 remains at least partially attached to the delivery tube 110.



FIG. 6A illustrates an exemplary implantation system having a sliding track 113a and a bump or protrusion 123a. The sliding track 113a can be cut from a portion of the delivery tube 110 near the proximal end 112 of the delivery tube 110. The interference feature 120 can have an engagement bump or protrusion 123a that is positioned to slide within the track 113a. The track 113a can extend along a portion of a length of the delivery tube 110, and the bump 123a can slide within the track 113a, allowing the interference feature 120 to move in a proximal direction in relation to the delivery tube 110. The track 113a can be L shaped, and the interference feature 120 can be twisted in relation to the delivery tube 110 and then pulled proximally in relation to the delivery tube 110 to move the interference feature 120 in relation to the delivery tube 110. The interference feature 120 can be attached to a pull wire 130, and the movement of the interference feature 120 can move the pull wire 130 to deploy an embolic implant 140. FIG. 6B illustrates a cross-sectional view near a proximal end of the exemplary implantation system as indicated in FIG. 6A.



FIG. 7A illustrates an exemplary implantation system having a stretchable segment 126. The implantation system can have a delivery tube 110 with a stretchable segment 126 positioned near a proximal end 112 of the delivery tube 110. The stretchable segment 126 can be a region of the delivery tube 110 that has a propensity to stretch in response to a force that creates tension along a length of the delivery tube 110 that includes the stretchable segment 126. The stretchable segment 126 can include a coil that is compressed in an initial state as illustrated in FIG. 7A, a laser cut portion of the tube, and/or a portion of tubing having greater elasticity. The stretchable segment 126 can extends in response to a force provided by the introducer sheath 180 against the interference feature 120. The stretchable segment 126 can allow the pull wire and the interference feature 120 to move proximally in relation to the delivery tube 110 without the interference feature 120 becoming disconnected from the delivery tube 110. The stretchable segment 126 can have a fully extended length that is determined by the material properties and/or construction of the stretchable segment 126. The fully extended length can limit the distance that the interference feature 120 can be moved proximally in relation to the delivery tube 110. FIG. 7B illustrates a cross-sectional view near a proximal end of the exemplary implantation system as indicated in FIG. 7A.



FIGS. 8A through 8C illustrate an exemplary implantation system having a stretchable element 126a and a detachment feature 122c. The disconnection feature 122c illustrated in FIGS. 8A through 8C can include notches 115B in a delivery tube 110, similar to that illustrated in FIGS. 4 and 4B. It is contemplated that other disconnection features, including the disconnection features illustrated in, and described in relation to FIGS. 1, 3A-3C, 5, or 5B could be combined with a stretchable segment like those described herein or otherwise known. When used in combination with the stretchable segment 126a, the disconnection feature 122c can be positioned along a length of the delivery tube 110 at or near the stretchable segment 126a. Both the stretchable segment 126a and the disconnection feature 122c can be positioned near the proximal end 112 of the delivery tube 110.



FIG. 8A illustrates the stretchable element 126a positioned within a lumen of the delivery tube 110 near the proximal end 112 of the delivery tube 110. In FIG. 8A, the delivery tube 110 is illustrated cut-away to show coils of the stretchable element 126a within. In the configuration illustrated in FIG. 8A, interference feature 120 can be attached to the delivery tube 110 via the stretchable element 126a and the detachment feature 122c.



FIG. 8B illustrates an introducer sheath 180 moved proximally to engage the interference feature 120, break the detachment feature 122c, and begin to stretch the stretchable element 126a. The delivery tube 110 and the introducer sheath 180 are shown cut-away. A pull wire 130 can be positioned within the delivery tube 110. The pull wire 130 can be pulled proximally as the interference feature 120 is moved proximally. The stretchable element 126a can be attached to the interference feature 120 with a weld, adhesive, or other connection 125. The stretchable element 126a can be attached to the delivery tube 110 with a weld, adhesive, or other connection 127. After the detachment feature 122c is detached, the stretchable element 126a can maintain an attachment between the interference feature 120 and the delivery tube 110.



FIG. 8C illustrates the introducer sheath 180 moved further proximally to move the interference feature 120 and pull wire 130 further proximally and further stretch the stretchable element 126a. The stretchable element 126a can have a fully extended length that is determined by the material properties and/or construction of the stretchable element 126a. The fully extended length can limit the distance that the interference feature 120 can be moved proximally in relation to the delivery tube 110.



FIG. 9 illustrates relative dimensions of a delivery system, microcatheter, and introducer sheath as known in the art. Known delivery systems are typically 200 cm long, known microcatheters are typically 165 cm long, and known introducer sheaths are typically 130 cm long. In known practices, the introducer sheath is typically removed after an embolic implant and any sensitive portions of the delivery system are inserted into the microcatheter. According to known practices, an introducer sheath cannot remain around the delivery system during the deployment step of the embolic implant because the combined length of known microcatheters and introducers is several centimeters longer than known delivery systems. It is an aspect of the present invention to size a delivery system and an introducer sheath so that the introducer sheath can remain on the delivery system through the embolic implant deployment step. In example systems presented herein, an implantation system can include a delivery system, microcatheter, and introducer sheath, wherein the delivery system is longer than the combined length of the microcatheter and the introducer sheath.


An aneurysm can be treated with an implantation system such as any of the implantation systems disclosed herein in relation to the present invention by executing some or all the following steps, not necessarily in order. An implantation system 100 having an embolic implant 140, an introducer sheath 180, a delivery tube 110, an interference feature 120, and a pull wire 130 can be provided. The pull wire 130 can be affixed to the interference feature 120. The pull wire 130 can be positioned within a lumen of the delivery tube 110. The interference feature 120 can be attached to a proximal end 112 of the delivery tube 110. The embolic implant 140 can be attached at a distal end 114 of the delivery tube 110. The introducer sheath 180 can be positioned to encompass the embolic implant 140 and a first portion of the delivery tube 110. The first portion of the delivery tube 110 can comprise a soft section 116. The introducer sheath can be sized to have an end-to-end length that is longer by about 5 cm than a length measurable from a distal end 144 of the embolic implant 140 to a proximal end 117 of the soft section 116. The introducer sheath 180 can be sized so that the end-to-end length is between about 46 cm and about 105 cm. A microcatheter 200 can be provided. The introducer sheath 180 can be positioned to engage with the microcatheter 200 while maintaining the embolic implant 140 and the first portion of the delivery tube 110 within the introducer sheath 180. The embolic implant 140 and the delivery tube 110 can be translated distally to position the embolic implant 140 and the first portion of the delivery tube 110 within the microcatheter 200. The introducer sheath 180 can be slid proximally over the delivery tube 110. The introducer sheath 180 can be pulled proximally to apply a force from the introducer sheath 180 to the interference feature 120. The interference feature 120 and the pull wire 130 can be moved proximally in relation to the delivery tube 110 in response to the force. The interference feature 120 can be detached from the delivery tube 110. The embolic implant 140 can be detached from the delivery tube 110 in response to moving the interference feature 120 and the pull wire 130 proximally in relation to the delivery tube 110.


The descriptions contained herein are examples of embodiments of the invention and are not intended in any way to limit the scope of the invention. As described herein, the invention contemplates many variations and modifications of the implantation system and associated methods, including alternative geometries of system components, alternative materials, additional or alternative method steps, etc. These modifications would be apparent to those having ordinary skill in the art to which this invention relates and are intended to be within the scope of the claims which follow.

Claims
  • 1. An implantation system comprising: a delivery tube comprising a lumen therethrough, a proximal end, and a distal end;an embolic coil detachably attached to the distal end of the delivery tube;an introducer sheath comprising a lumen therethrough sized to slidably receive the delivery tube and the embolic coil;an interference feature positioned approximate the proximal end of the delivery tube; andan elongated member disposed within the lumen of the delivery tube and attached to the interference feature, wherein the introducer sheath is translatable over the delivery tube from the distal end of the delivery tube to the proximal end of the delivery tube and is sized to engage the interference feature,wherein the interference feature is movable in relation to the delivery tube in response to a force applied by the introducer sheath against the interference feature, andwherein the elongated member is movable in relation to the delivery tube in response to a proximal movement of the interference feature.
  • 2. The system of claim 1 wherein the interference feature is detachable from the delivery tube and wherein the elongated member is movable to exit the proximal end of the delivery tube in response to a proximal movement of the detached interference feature.
  • 3. The system of claim 1wherein the delivery tube comprises a soft section disposed approximate the distal end of the delivery tube,wherein a first length is measurable from a distal end of the embolic coil to a proximal end of the soft section, andwherein the introducer sheath comprises a second length measurable from a distal end to a proximal end of the introducer sheath, the second length measuring greater than the first length by about 5 cm.
  • 4. The system of claim 3 further comprising a microcatheter comprising a third length measurable from a distal end to a proximal end of the microcatheter, and wherein the delivery tube comprises a fourth length measurable from the distal end to the proximal end of the delivery tube, the fourth length measuring greater than the sum of the third length and the second length.
  • 5. The system of claim 1 wherein the introducer sheath comprises a length of between about 46 cm to about 105 cm, the length measurable from a distal end to a proximal end of the introducer sheath.
  • 6. The system of claim 1wherein the delivery tube comprises a soft section disposed approximate the distal end of the delivery tube, andwherein the introducer sheath is movable from a packaged configuration in which the introducer sheath is positioned to completely encompass the soft section and the embolic coil to a deployment configuration in which the introducer sheath is engaged with the interference feature.
  • 7. The system of claim 1 wherein the embolic coil is detachable from the delivery tube in response to a proximal movement of the elongated member in relation to the delivery tube.
  • 8. The system of claim 1 wherein the interference feature comprises a substantially circular surface positioned to engage the proximal end of the introducer sheath.
  • 9. An implantation assembly comprising: a delivery tube comprising a lumen therethrough, a proximal end, and a distal end;an embolic implant attached to the distal end of the delivery tube;a pull wire disposed within the lumen of the delivery tube and movable to detach the embolic implant from the delivery tube;an engagement bump disposed on a proximal end of the pull wire and positioned approximate the proximal end of the delivery tube; anda tubular sheath conveyable over the embolic implant and the delivery tube from a distal end of the embolic implant to the proximal end of the delivery tube, the tubular sheath sized to engage the engagement bump, wherein the engagement bump and the pull wire are movable in relation to the delivery tube in response to a force applied by the tubular sheath to the engagement bump.
  • 10. The assembly of claim 9wherein the delivery tube comprises a soft section extending proximally from the distal end of the delivery tube,wherein a first length is measurable from the distal end of the embolic implant to a proximal end of the soft section, andwherein the tubular sheath comprises a second length measurable from a distal end to a proximal end of the tubular sheath, the second length measuring greater than the first length by about 5 cm.
  • 11. The assembly of claim 10 further comprising a microcatheter comprising a third length measurable from a distal end to a proximal end of the microcatheter, and wherein the delivery tube comprises a fourth length measurable from the distal end of the delivery tube to the proximal end of the delivery tube, the fourth length measuring greater than the sum of the third length and the second length.
  • 12. The assembly of claim 9wherein the delivery tube comprises a soft section extending proximally from the distal end of the delivery tube, andwherein the tubular sheath is movable from a packaged configuration in which the tubular sheath is positioned to completely encompass the soft section and the embolic implant to a deployment configuration in which the tubular sheath is engaged with the engagement bump.
  • 13. The assembly of claim 9 wherein the engagement bump is detachable from the delivery tube in response to the force applied by the tubular sheath.
  • 14. The assembly of claim 9 wherein pull wire is movable to detach the embolic implant from the delivery tube in response to the force applied by the tubular sheath.
  • 15. A method for treating an aneurysm comprising: providing an implantation system comprising an embolic implant, an introducer sheath, a delivery tube, an interference feature, and a pull wire;affixing the pull wire to the interference feature;positioning the pull wire within a lumen of the delivery tube;attaching the interference feature to a proximal end of the delivery tube;attaching the embolic implant at a distal end of the delivery tube;positioning the introducer sheath to encompass the embolic implant and a first portion of the delivery tube;sliding the introducer sheath proximally over the delivery tube;pulling the introducer sheath proximally to apply a force from the introducer sheath to the interference feature; andmoving the interference feature and the pull wire proximally in relation to the delivery tube in response to the force.
  • 16. The method of claim 15wherein the first portion of the delivery tube comprises a soft section, andwherein a first length is measurable from a distal end of the embolic implant to a proximal end of the soft section,the method further comprising sizing the introducer sheath to comprise a second length measurable from a distal end to a proximal end of the introducer sheath, the second length measuring greater than the first length by about 5 cm.
  • 17. The method of claim 15 further comprising sizing the introducer sheath to comprise a length of between about 46 cm to about 105 cm, the length measurable from a distal end to a proximal end of the introducer sheath.
  • 18. The method of claim 15 further comprising detaching the embolic implant from the delivery tube in response to moving the interference feature and the pull wire proximally in relation to the delivery tube.
  • 19. The method of claim 15 further comprising detaching the interference feature from the delivery tube.
  • 20. The method of claim 15 further comprising: providing a microcatheter;positioning the introducer sheath to engage with the microcatheter while maintaining the embolic implant and the first portion of the delivery tube within the introducer sheath; andtranslating the embolic implant and the delivery tube distally to position the embolic implant and the first portion of the delivery tube within the microcatheter.
US Referenced Citations (244)
Number Name Date Kind
3429408 Maker et al. Feb 1969 A
5108407 Geremia et al. Apr 1992 A
5122136 Guglielmi et al. Jun 1992 A
5250071 Palermo Oct 1993 A
5263964 Purdy Nov 1993 A
5334210 Gianturco Aug 1994 A
5350397 Palermo et al. Sep 1994 A
5382259 Phelps et al. Jan 1995 A
5484409 Atkinson et al. Jan 1996 A
5569221 Houser et al. Oct 1996 A
5899935 Ding May 1999 A
5925059 Palermo et al. Jul 1999 A
6113622 Hieshima Sep 2000 A
6203547 Nguyen et al. Mar 2001 B1
6391037 Greenhalgh May 2002 B1
6454780 Wallace Sep 2002 B1
6506204 Mazzocchi Jan 2003 B2
6561988 Turturro et al. May 2003 B1
7367987 Balgobin et al. May 2008 B2
7371251 Mitelberg et al. May 2008 B2
7371252 Balgobin et al. May 2008 B2
7377932 Mitelberg et al. May 2008 B2
7708754 Balgobin et al. May 2010 B2
7708755 Davis, III et al. May 2010 B2
7799052 Balgobin et al. Sep 2010 B2
7811305 Balgobin et al. Oct 2010 B2
7819891 Balgobin et al. Oct 2010 B2
7819892 Balgobin et al. Oct 2010 B2
7901444 Slazas Mar 2011 B2
7985238 Balgobin et al. Jul 2011 B2
8062325 Mitelberg et al. Nov 2011 B2
8333796 Tompkins et al. Dec 2012 B2
9155540 Lorenzo Oct 2015 B2
9232992 Heidner et al. Jan 2016 B2
9314326 Wallace et al. Apr 2016 B2
9532792 Galdonik et al. Jan 2017 B2
9532873 Kelley Jan 2017 B2
9533344 Monetti et al. Jan 2017 B2
9539011 Chen et al. Jan 2017 B2
9539022 Bowman Jan 2017 B2
9539122 Burke et al. Jan 2017 B2
9539382 Nelson Jan 2017 B2
9549830 Bruszewski et al. Jan 2017 B2
9554805 Tompkins et al. Jan 2017 B2
9561125 Bowman et al. Feb 2017 B2
9572982 Burnes et al. Feb 2017 B2
9579484 Barnell Feb 2017 B2
9585642 Dinsmoor et al. Mar 2017 B2
9615832 Bose et al. Apr 2017 B2
9615951 Bennett et al. Apr 2017 B2
9622753 Cox Apr 2017 B2
9636115 Henry et al. May 2017 B2
9636439 Chu et al. May 2017 B2
9642675 Werneth et al. May 2017 B2
9655633 Leynov et al. May 2017 B2
9655645 Staunton May 2017 B2
9655989 Cruise et al. May 2017 B2
9662120 Lagodzki et al. May 2017 B2
9662129 Galdonik et al. May 2017 B2
9662238 Dwork et al. May 2017 B2
9662425 Lilja et al. May 2017 B2
9668898 Wong Jun 2017 B2
9675477 Thompson Jun 2017 B2
9675782 Connolly Jun 2017 B2
9676022 Ensign Jun 2017 B2
9692557 Murphy Jun 2017 B2
9693852 Lam et al. Jul 2017 B2
9700262 Janik et al. Jul 2017 B2
9700399 Acosta-Acevedo Jul 2017 B2
9717421 Griswold et al. Aug 2017 B2
9717500 Tieu et al. Aug 2017 B2
9717502 Teoh et al. Aug 2017 B2
9724103 Cruise et al. Aug 2017 B2
9724526 Strother et al. Aug 2017 B2
9750565 Bloom et al. Sep 2017 B2
9757260 Greenan Sep 2017 B2
9764111 Gulachenski Sep 2017 B2
9770251 Bowman Sep 2017 B2
9770577 Li Sep 2017 B2
9775621 Tompkins et al. Oct 2017 B2
9775706 Paterson Oct 2017 B2
9775732 Khenansho Oct 2017 B2
9788800 Mayoras, Jr. Oct 2017 B2
9795391 Saatchi et al. Oct 2017 B2
9801980 Karino et al. Oct 2017 B2
9808599 Bowman Nov 2017 B2
9833252 Sepetka Dec 2017 B2
9833604 Lam Dec 2017 B2
9833625 Waldhauser et al. Dec 2017 B2
9918718 Lorenzo Mar 2018 B2
10285710 Lorenzo et al. May 2019 B2
10517604 Bowman et al. Dec 2019 B2
10806402 Cadieu et al. Oct 2020 B2
10806461 Lorenzo Oct 2020 B2
20010049519 Holman et al. Dec 2001 A1
20020072705 Vrba et al. Jun 2002 A1
20020165569 Ramzipoor et al. Nov 2002 A1
20040034363 Wilson et al. Feb 2004 A1
20040059367 Davis Mar 2004 A1
20040087964 Diaz May 2004 A1
20060025801 Lulo et al. Feb 2006 A1
20060064151 Guterman et al. Mar 2006 A1
20060116711 Elliott et al. Jun 2006 A1
20060116714 Sepetka et al. Jun 2006 A1
20060135986 Wallace et al. Jun 2006 A1
20060206139 Tekulve Sep 2006 A1
20060247677 Cheng et al. Nov 2006 A1
20060276824 Mitelberg et al. Dec 2006 A1
20060276825 Mitelberg et al. Dec 2006 A1
20060276826 Mitelberg et al. Dec 2006 A1
20060276827 Mitelberg et al. Dec 2006 A1
20060276830 Balgobin et al. Dec 2006 A1
20060276833 Balgobin et al. Dec 2006 A1
20070010850 Balgobin Jan 2007 A1
20070055302 Henry et al. Mar 2007 A1
20070083132 Sharrow Apr 2007 A1
20070233168 Davis et al. Oct 2007 A1
20070270903 Davis, III et al. Nov 2007 A1
20080027561 Mitelberg et al. Jan 2008 A1
20080045997 Balgobin et al. Feb 2008 A1
20080097462 Mitelberg et al. Apr 2008 A1
20080281350 Sepetka et al. Nov 2008 A1
20080300616 Que et al. Dec 2008 A1
20080306503 Que et al. Dec 2008 A1
20090062726 Ford et al. Mar 2009 A1
20090312748 Johnson et al. Dec 2009 A1
20100114017 Lenker et al. May 2010 A1
20100324649 Mattsson et al. Dec 2010 A1
20110202085 Loganathan et al. Aug 2011 A1
20110295303 Freudenthal Dec 2011 A1
20120035707 Mitelberg et al. Feb 2012 A1
20120041472 Tan et al. Feb 2012 A1
20120283768 Cox et al. Nov 2012 A1
20130066413 Jin Mar 2013 A1
20140058435 Jones et al. Feb 2014 A1
20140135812 Divino et al. May 2014 A1
20140200607 Sepetka et al. Jul 2014 A1
20140277084 Mirigian et al. Sep 2014 A1
20140277085 Mirigian et al. Sep 2014 A1
20140277092 Teoh et al. Sep 2014 A1
20140277093 Guo Sep 2014 A1
20150005808 Chouinard et al. Jan 2015 A1
20150182227 Le Jul 2015 A1
20150230802 Lagodzki et al. Aug 2015 A1
20150335333 Jones et al. Nov 2015 A1
20160008003 Kleshinski et al. Jan 2016 A1
20160022275 Garza Jan 2016 A1
20160157869 Elgård et al. Jun 2016 A1
20160228125 Pederson, Jr. Aug 2016 A1
20160310304 Mialhe Oct 2016 A1
20160346508 Williams et al. Dec 2016 A1
20170007264 Cruise et al. Jan 2017 A1
20170007265 Guo et al. Jan 2017 A1
20170020670 Murray et al. Jan 2017 A1
20170020700 Bienvenu Jan 2017 A1
20170027640 Kunis et al. Feb 2017 A1
20170027692 Bonhoeffer Feb 2017 A1
20170027725 Argentine Feb 2017 A1
20170035436 Morita Feb 2017 A1
20170035567 Duffy Feb 2017 A1
20170042548 Lam Feb 2017 A1
20170049596 Schabert Feb 2017 A1
20170071737 Kelley Mar 2017 A1
20170072452 Monetti et al. Mar 2017 A1
20170079671 Morero Mar 2017 A1
20170079680 Bowman Mar 2017 A1
20170079766 Wang Mar 2017 A1
20170079767 Leon-Yip Mar 2017 A1
20170079812 Lam et al. Mar 2017 A1
20170079817 Sepetka Mar 2017 A1
20170079819 Pung et al. Mar 2017 A1
20170079820 Lam et al. Mar 2017 A1
20170086851 Wallace Mar 2017 A1
20170086996 Peterson et al. Mar 2017 A1
20170095258 Tassoni et al. Apr 2017 A1
20170095259 Tompkins et al. Apr 2017 A1
20170100126 Bowman et al. Apr 2017 A1
20170100141 Morero et al. Apr 2017 A1
20170100143 Granfield Apr 2017 A1
20170100183 Iaizzo Apr 2017 A1
20170113023 Steingisser et al. Apr 2017 A1
20170147765 Mehta May 2017 A1
20170151032 Loisel Jun 2017 A1
20170165062 Rothstein Jun 2017 A1
20170165065 Rothstein Jun 2017 A1
20170165454 Tuohy Jun 2017 A1
20170172581 Bose et al. Jun 2017 A1
20170172766 Vong et al. Jun 2017 A1
20170172772 Khenansho Jun 2017 A1
20170189033 Sepetka et al. Jul 2017 A1
20170189035 Porter Jul 2017 A1
20170215902 Leynov et al. Aug 2017 A1
20170216484 Cruise et al. Aug 2017 A1
20170224350 Shimizu et al. Aug 2017 A1
20170224355 Bowman et al. Aug 2017 A1
20170224467 Piccagli et al. Aug 2017 A1
20170224511 Dwork et al. Aug 2017 A1
20170224953 Tran et al. Aug 2017 A1
20170231749 Perkins et al. Aug 2017 A1
20170245864 Franano et al. Aug 2017 A1
20170245885 Lenker Aug 2017 A1
20170252064 Staunton Sep 2017 A1
20170258476 Hayakawa et al. Sep 2017 A1
20170265983 Lam et al. Sep 2017 A1
20170281192 Tieu et al. Oct 2017 A1
20170281331 Perkins et al. Oct 2017 A1
20170281344 Costello Oct 2017 A1
20170281909 Northrop et al. Oct 2017 A1
20170281912 Melder Oct 2017 A1
20170290593 Cruise et al. Oct 2017 A1
20170290654 Sethna Oct 2017 A1
20170296324 Argentine Oct 2017 A1
20170296325 Marrocco et al. Oct 2017 A1
20170303939 Greenhalgh Oct 2017 A1
20170303942 Greenhalgh et al. Oct 2017 A1
20170303947 Greenhalgh Oct 2017 A1
20170303948 Wallace et al. Oct 2017 A1
20170304041 Argentine Oct 2017 A1
20170304097 Corwin et al. Oct 2017 A1
20170304595 Nagasrinivasa Oct 2017 A1
20170312109 Le Nov 2017 A1
20170312484 Shipley et al. Nov 2017 A1
20170316561 Helm et al. Nov 2017 A1
20170319826 Bowman Nov 2017 A1
20170333228 Orth et al. Nov 2017 A1
20170333236 Greenan Nov 2017 A1
20170333678 Bowman Nov 2017 A1
20170340383 Bloom et al. Nov 2017 A1
20170348014 Wallace Dec 2017 A1
20170348514 Guyon et al. Dec 2017 A1
20180028779 von Oepen et al. Feb 2018 A1
20180036508 Ozasa et al. Feb 2018 A1
20180228493 Aguilar et al. Aug 2018 A1
20180250150 Majercak Sep 2018 A1
20180280667 Keren Oct 2018 A1
20180325706 Hebert Nov 2018 A1
20190159784 Sananes et al. May 2019 A1
20190192162 Lorenzo Jun 2019 A1
20190255290 Snyder et al. Aug 2019 A1
20190314033 Mirigian et al. Oct 2019 A1
20190328398 Lorenzo Oct 2019 A1
20200138448 Dasnurkar et al. May 2020 A1
20200187951 Blumenstyk Jun 2020 A1
20210001082 Lorenzo et al. Jan 2021 A1
Foreign Referenced Citations (11)
Number Date Country
1985244 Oct 2008 EP
2498691 Sep 2012 EP
3092956 Nov 2016 EP
3501427 Jun 2019 EP
2006-334408 Dec 2006 JP
2012-523943 Oct 2012 JP
2013-78584 May 2013 JP
WO 2009132045 Oct 2009 WO
WO 2012158152 Nov 2012 WO
WO 2017066386 Apr 2017 WO
WO 2018022186 Feb 2018 WO
Non-Patent Literature Citations (3)
Entry
Extended European Search Report issued in corresponding European Patent Application No. 19 21 5318 dated Apr. 8, 2020.
Extended European Search Report issued in corresponding European Patent Application No. 20 21 2970 dated May 28, 2021.
Extended European Search Report issued in European Patent Application No. 21 15 6857 dated Jun. 22, 2021.
Related Publications (1)
Number Date Country
20200187951 A1 Jun 2020 US